Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

When Communicating Product Risks, FDA Should Involve Firms – AdvaMed

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed is urging FDA to "routinely" consult with manufacturers when developing and evaluating safety-related communications about devices, drugs and other regulated products

You may also be interested in...



FDA Risk Communication Plan May Be Released Within A Month

FDA's strategic plan for ensuring the public receives accurate and balanced information about the risks and benefits of medical products could be released within a month, according to FDA Center for Drug Evaluation and Research Director Janet Woodcock

FDA Risk Communication Plan May Be Released Within A Month

FDA's strategic plan for ensuring the public receives accurate and balanced information about the risks and benefits of medical products could be released within a month, according to FDA Center for Drug Evaluation and Research Director Janet Woodcock

Heart Rhythm Experts Release New Pacer/ICD Lead Management Guidelines

New recommendations from leading heart experts call on physicians, device manufacturers and FDA to do a better job monitoring and managing the safety of pacemaker and implantable defibrillator leads

Topics

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel